Preserving fertility in patients undergoing treatment for breast cancer: current perspectives

Rebecca Moffat,1 Uwe Güth2 1Women’s Hospital, Clinic for Gynecologic Endocrinology and Reproductive Medicine, University Hospital Basel, Basel, 2Department of Gynecology and Obstetrics, Breast Center, SenoSuisse, Cantonal Hospital Winterthur, Winterthur, Switzerland Abstract: In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Moffat R, Güth U
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/8a52c3b14f614593b150107f40da4d5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8a52c3b14f614593b150107f40da4d5c
record_format dspace
spelling oai:doaj.org-article:8a52c3b14f614593b150107f40da4d5c2021-12-02T06:33:50ZPreserving fertility in patients undergoing treatment for breast cancer: current perspectives1179-1314https://doaj.org/article/8a52c3b14f614593b150107f40da4d5c2014-07-01T00:00:00Zhttp://www.dovepress.com/preserving-fertility-in-patients-undergoing-treatment-for-breast-cance-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314 Rebecca Moffat,1 Uwe Güth2 1Women’s Hospital, Clinic for Gynecologic Endocrinology and Reproductive Medicine, University Hospital Basel, Basel, 2Department of Gynecology and Obstetrics, Breast Center, SenoSuisse, Cantonal Hospital Winterthur, Winterthur, Switzerland Abstract: Invasive breast cancer (BC) is the most frequent cancer of young women. Considering the trend toward postponing childbearing until the later reproductive years, the number of childless women at diagnosis of BC will continue to increase. The American Society of Clinical Oncology and the American Society for Reproductive Medicine have recommended that the impact of cancer treatments on fertility should be addressed with all cancer patients of reproductive age and that options for fertility preservation, such as cryopreservation of embryos and oocytes, ovarian tissue, in vitro maturation of immature oocytes, and ovarian suppression with gonadotropin-releasing hormone analogs, should be discussed routinely. To optimally counsel patients on how to best weigh the risks and benefits of fertility preservation, both the health care provider and the patient must know about the options, their risks, and their likelihood of success. The aim of this review is to summarize current knowledge on fertility preservation options for young BC patients, surrogates of ovarian function, psychosocial aspects of infertility after cancer treatment, women’s attitudes towards childbearing after cancer treatment, and health care providers’ attitudes towards fertility preservation. Keywords: breast cancer, fertility preservation, oncofertility, chemotherapyMoffat RGüth UDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2014, Iss default, Pp 93-101 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Moffat R
Güth U
Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
description Rebecca Moffat,1 Uwe Güth2 1Women’s Hospital, Clinic for Gynecologic Endocrinology and Reproductive Medicine, University Hospital Basel, Basel, 2Department of Gynecology and Obstetrics, Breast Center, SenoSuisse, Cantonal Hospital Winterthur, Winterthur, Switzerland Abstract: Invasive breast cancer (BC) is the most frequent cancer of young women. Considering the trend toward postponing childbearing until the later reproductive years, the number of childless women at diagnosis of BC will continue to increase. The American Society of Clinical Oncology and the American Society for Reproductive Medicine have recommended that the impact of cancer treatments on fertility should be addressed with all cancer patients of reproductive age and that options for fertility preservation, such as cryopreservation of embryos and oocytes, ovarian tissue, in vitro maturation of immature oocytes, and ovarian suppression with gonadotropin-releasing hormone analogs, should be discussed routinely. To optimally counsel patients on how to best weigh the risks and benefits of fertility preservation, both the health care provider and the patient must know about the options, their risks, and their likelihood of success. The aim of this review is to summarize current knowledge on fertility preservation options for young BC patients, surrogates of ovarian function, psychosocial aspects of infertility after cancer treatment, women’s attitudes towards childbearing after cancer treatment, and health care providers’ attitudes towards fertility preservation. Keywords: breast cancer, fertility preservation, oncofertility, chemotherapy
format article
author Moffat R
Güth U
author_facet Moffat R
Güth U
author_sort Moffat R
title Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
title_short Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
title_full Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
title_fullStr Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
title_full_unstemmed Preserving fertility in patients undergoing treatment for breast cancer: current perspectives
title_sort preserving fertility in patients undergoing treatment for breast cancer: current perspectives
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/8a52c3b14f614593b150107f40da4d5c
work_keys_str_mv AT moffatr preservingfertilityinpatientsundergoingtreatmentforbreastcancercurrentperspectives
AT guthu preservingfertilityinpatientsundergoingtreatmentforbreastcancercurrentperspectives
_version_ 1718399884294356992